SC 13G
FENNEC PHARMACEUTICALS INC.
- Company
- FENNEC PHARMACEUTICALS INC.
- Filed
- February 12, 2018
- Accession Number
- 0000902664-18-000890
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →